文献
J-GLOBAL ID:201702213974400005
整理番号:17A1493239
アルツハイマー病における脳脊髄液YKL-40を用いた2レベル診断分類【Powered by NICT】
Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer’s disease
著者 (26件):
Baldacci Filippo
(Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy)
,
Baldacci Filippo
(Sorbonne Universites, Universite Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Departement de Neurologie, Institut de la Memoire et de la Maladie d’Alzheimer (IM2A), Hopital Pitie-Salpetriere, Boulevard de l’hopital, Paris, France)
,
Toschi Nicola
(Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy)
,
Toschi Nicola
(Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA)
,
Lista Simone
(Sorbonne Universites, Universite Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Departement de Neurologie, Institut de la Memoire et de la Maladie d’Alzheimer (IM2A), Hopital Pitie-Salpetriere, Boulevard de l’hopital, Paris, France)
,
Lista Simone
(AXA Research Fund & UPMC Chair, Paris, France)
,
Zetterberg Henrik
(Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Molndal, Sweden)
,
Zetterberg Henrik
(Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Molndal, Sweden)
,
Zetterberg Henrik
(Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK)
,
Blennow Kaj
(Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Molndal, Sweden)
,
Blennow Kaj
(Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Molndal, Sweden)
,
Kilimann Ingo
(Department of Psychosomatic Medicine, University of Rostock and DZNE, Rostock, Germany)
,
Teipel Stefan
(Department of Psychosomatic Medicine, University of Rostock and DZNE, Rostock, Germany)
,
Cavedo Enrica
(Sorbonne Universites, Universite Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Departement de Neurologie, Institut de la Memoire et de la Maladie d’Alzheimer (IM2A), Hopital Pitie-Salpetriere, Boulevard de l’hopital, Paris, France)
,
Cavedo Enrica
(AXA Research Fund & UPMC Chair, Paris, France)
,
Cavedo Enrica
(IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy)
,
dos Santos Antonio Melo
(Sorbonne Universites, Universite Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Departement de Neurologie, Institut de la Memoire et de la Maladie d’Alzheimer (IM2A), Hopital Pitie-Salpetriere, Boulevard de l’hopital, Paris, France)
,
Epelbaum Stephane
(Sorbonne Universites, Universite Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Departement de Neurologie, Institut de la Memoire et de la Maladie d’Alzheimer (IM2A), Hopital Pitie-Salpetriere, Boulevard de l’hopital, Paris, France)
,
Lamari Foudil
(AP-HP, UF Biochimie des Maladies Neuro-metaboliques, Service de Biochimie Metabolique, Groupe Hospitalier Pitie-Salpetriere, Paris, France)
,
Dubois Bruno
(Sorbonne Universites, Universite Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Departement de Neurologie, Institut de la Memoire et de la Maladie d’Alzheimer (IM2A), Hopital Pitie-Salpetriere, Boulevard de l’hopital, Paris, France)
,
Floris Roberto
(Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy)
,
Garaci Francesco
(Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy)
,
Garaci Francesco
(Casa di Cura “San Raffaele Cassino”, Cassino, Frosinone, Italy)
,
Bonuccelli Ubaldo
(Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy)
,
Hampel Harald
(Sorbonne Universites, Universite Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Departement de Neurologie, Institut de la Memoire et de la Maladie d’Alzheimer (IM2A), Hopital Pitie-Salpetriere, Boulevard de l’hopital, Paris, France)
,
Hampel Harald
(AXA Research Fund & UPMC Chair, Paris, France)
資料名:
Alzheimer’s & Dementia: Journal of the Alzheimer’s Association
(Alzheimer's & Dementia: Journal of the Alzheimer's Association)
巻:
13
号:
9
ページ:
993-1003
発行年:
2017年
JST資料番号:
W3115A
ISSN:
1552-5260
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)